Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Chewy (NYSE:CHWY) in the last three months.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 4 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 2 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Chewy, presenting an average target of $45.0, a high estimate of $52.00, and a low estimate of $28.00. This current average has decreased by 5.86% from the previous average price target of $47.80.

An in-depth analysis of recent analyst actions unveils how financial experts perceive Chewy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| John Blackledge | TD Cowen | Lowers | Buy | $39.00 | $48.00 |
| Trevor Young | Barclays | Lowers | Overweight | $48.00 | $52.00 |
| Rick Patel | Raymond James | Announces | Outperform | $28.00 | - |
| Lauren Schenk | Morgan Stanley | Raises | Overweight | $51.00 | $48.00 |
| Alexandra Steiger | Goldman Sachs | Raises | Buy | $52.00 | $44.00 |
| Trevor Young | Barclays | Raises | Overweight | $52.00 | $47.00 |
Capture valuable insights into Chewy's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Chewy analyst ratings.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending time developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Positive Revenue Trend: Examining Chewy's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 8.31% as of 31 October, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Chewy's net margin is impressive, surpassing industry averages. With a net margin of 1.9%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Chewy's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 13.78%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Chewy's ROA excels beyond industry benchmarks, reaching 1.85%. This signifies efficient management of assets and strong financial health.
Debt Management: Chewy's debt-to-equity ratio stands notably higher than the industry average, reaching 1.11. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.